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Abstract 
The Absorption before leakage (ABL) method for measuring the absorption capacity 
of urine absorbing aids was investigated. Along with the existing international 
standard (ISO 11948-1, the Rothwell method [1]), it was run on 12 experimental 
products whose in-use leakage performance was established by 55 incontinent 
nursing home residents. Methods were evaluated by considering their simplicity, their 
repeatability within - and their reproducibility between - six laboratories, and their 
correlation with in-use product performance. ISO 11948-1 – which measures the 
absorption capacity of products under simple conditions - showed good repeatability 
and reproducibility, and reasonable correlation with in–use data. However, it proved 
blind to the effects of leg cuffs that conferred measurable benefits in real use. It 
should, therefore, be used with caution. The ABL method – which measures how 
much a product will hold before leakage when it is mounted on a manikin and 
standard aliquots of liquid are applied - is more complex and had poorer repeatability 
and reproducibility. However, it had stronger correlations with in-use data and 
successfully detected the benefits of leg cuffs on insert products. It is concluded that 
it holds potential as a new international standard to replace or complement ISO 
11948-1, and the necessary refinement work has been ongoing since the 2007 
project described here.     
 
Two other laboratory methods were run opportunistically. A rewet method (Spanish 
national standard UNE 153601-2:2008 [2]) - for measuring the escape of fluid from a 
product under pressure – showed poor repeatability and reproducibility. Finally, an 
acquisition method was used to measure how quickly products absorbed two 
successive standard aliquots of liquid. It proved robust, showing good repeatability 
and reproducibility. Although measurements generally correlated well with in-use 
leakage performance, a direct causal link is unlikely. Products with high absorption 
capacity tend also to absorb quickly.    
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Single-use, urine absorbing aids - the mainstay products for managing intractable 
moderate / heavy urinary incontinence - come in only a limited number of different 
generic designs but each is available in many variants from different companies. As a 
result, buyers face the challenge of choosing from a bewildering array of products 
which, though having similar appearance, may vary considerably in both price and 
performance. Traditionally, purchasing bodies have run user evaluations to compare 
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products before making bulk-buying decisions but this has become increasingly 
impractical; unless they are pointlessly small, user evaluations are prohibitively time-
consuming and expensive and they yield data of only limited shelf-life as companies 
typically change their products over time in their quest for improvement. For this 
reason, an international laboratory standard to measure the leakage performance of 
products - the key functional requirement - was developed during the 1990s (ISO 
11948-1 [1]) and was subsequently used by purchasing agencies to help with product 
selection. It involves measuring the absorption capacity of a product under simple 
laboratory conditions and published studies show that this capacity correlated quite 
well with the leakage performance of products in real use up to about the year 2000 
[3, 4]. However, the method has well-documented shortcomings [4, 5], the most 
fundamental of which is that it merely measures the absorption capacity of the 
materials in a product, ignoring any benefits to leakage performance that might be 
conferred by such features as elasticated cuffs to impede lateral leakage, or carefully 
engineered composite core structures. In response, a group of companies belonging 
to EDANA - the International Association serving the Nonwovens and related 
Industries (referred to as the EDANA group in this paper) - initiated a project to 
develop a new method (the Absorption before leakage (ABL) method) which aimed to 
address the limitations of ISO 11948-1. The aim of the work described here was to 
investigate the potential for developing the ABL method as an international standard 
test method, and the strategy was to evaluate it alongside ISO 11948-1 by gathering 
and comparing data from laboratory and in-use measurements on a set of 12 
different products. In addition, the opportunity was taken to run too other laboratory 
methods (measuring rewet performance and acquisition time) which – though not 
seen as rival contenders to ABL for a new standard – might yet deliver useful insights 
on product performance.    
 
2 Materials: the experimental products 
The 12 product variants used for the work were specified by the EDANA group and 
manufactured in 20071 by the six participating companies (Arboria & Ausonia 
S.L.Unipersonal, Spain; Laboratorios Indas S.A., Spain; Ontex N.V., Belgium; 
Paperpak Sweden AB, Sweden; Paul Hartmann AG, Germany; and SCA Personal 
Health Care, Sweden). They comprised six variants of a brief design (two intended 
for day use and four for night use) and six variants of an insert design (four intended 
for day use and two for night use). Single use (as opposed to washable) briefs and 
inserts (Fig 1) are the two primary absorbent product designs currently used by men  
and women with moderate to heavy urinary incontinence. The inserts were used as 
part of a two-piece system in which the product was secured in position with close 
fitting stretch pants (net or mesh), each manufacturer supplying their own pants for 
use solely with their inserts. The brief is an all-in-one design with built in resealable 
adhesive tabs to facilitate optimum positioning. The briefs and stretch pants were 
supplied to fit a ‘medium’ body size; the inserts were each supplied in one size / 
absorbency level only. 
 
[insert Figure 1.] 
 
                                            
1  Although products have evolved since 2007, the generic designs of the products described here 
have not changed dramatically; products continue to incorporate variations on - and developments of - 
the design elements of the 2007 products. 
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The key features of the 12 product variants are summarised in Table 1. Many of the 
variants were designed to be considered in pairs; for example, variants 1 and 2 were 
identical apart from (not) having cuffs. The coefficient of variation of the dry weights 
for products coming off a regular production line is typically around 10% but, in order 
to reduce noise in the data for the current project, only those products with weights 
close to a target value for a given variant were retained. As a result, no coefficient of 
variation exceeded 1.5% (Table 1). The dry weight of the labeled bags in which used 
products were saved for weighing (see below) was 4.4g. 
 
[insert Table 1.] 
 
Although the product variants were manufactured specifically for this study, only 
materials and methods already in use with products commercially available in the UK 
were used in their construction, an important requirement for securing ethics 
committee approval. Individual products and packaging were supplied ‘unbranded’; 
that is, they did not display any print that could link them to their manufacturer.  
 
 
3 Methods: laboratory studies 
Each of the six companies in the EDANA Group ran the same four laboratory test 
methods on all 12 product variants and pooled their data for analysis. The first 
method (Fig 2) was ISO 11948-1 (often known as the Rothwell method, after the 
pharmacist who devised it), the existing international standard method for measuring 
the absorption capacity of products [1]. A product is laid flat on a horizontal, coarse 
wire grid with its water-permeable surface facing downwards and lowered into a 
reservoir of normal saline. After 30 min of soaking, the grid is raised and the product 
is allowed to drain under gravity for 5 min. The wet product is weighed and its dry 
mass subtracted to determine the mass of liquid absorbed. 
 
[insert Figure 2.] 
 
Second, was the ABL method (Fig 3) developed by the EDANA group as a potential 
international standard method to replace or complement ISO 11948-1. It involves 
delivering aliquots of 162 ml of normal saline into a product secured on an 
anatomically accurate manikin held in the posture shown in Fig 3. The flow-rate-time 
profile with which the aliquots are delivered – by a computer-controlled pump, and via 
a “urethra” – was chosen to mimic one of a set of flow-rate time profiles from patients 
in a urodynamics clinic (Fig 4). Aliquots of liquid are delivered repeatedly until 
leakage is observed from the product, with five minute intervals between the end of 
one delivery and the beginning of the next. If leakage begins during the delivery of an 
aliquot, the full aliquot is still delivered. The wet product is then weighed and its dry 
mass subtracted to determine the absorption before leakage (ABL) of the product.  
 
[insert Figure 3 and Figure 4.] 
 
The remaining two methods were included opportunistically to provide 
complementary data and insights, rather than being considered as rivals to the ABL 
method as candidates for a new international standard relating to product leakage 
performance. One method (Fig 5) was a rewet test chosen to represent a number of 
somewhat similar procedures that are used for measuring how readily liquid that is 
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already in a product escapes under pressure. It is published as Spanish national 
standard UNE 153601-2:2008 [2]. A weighted circular plate (diameter, 107 mm) is 
applied to the crotch region of a product laid flat and horizontal with its water-
permeable surface facing upwards and two aliquots of 150 ml of normal saline are 
delivered under gravity from a dropping funnel into a cylinder from which liquid enters 
the product through a central hole (diameter 21 mm) in the plate. The weight of the 
delivery apparatus (excluding the liquid) is 3.7 kg. The dropping funnel tap is opened 
to start the delivery of the second aliquot 15 min after the funnel has finished 
delivering the first into the chamber. A further 15 min after the dropping funnel tap 
has been opened for the second time, the fluid delivery apparatus is removed from 
the product and replaced by a stack of 30 filter papers (90 mm diameter, and known 
dry weight), and loaded with a 90 mm diameter Perspex plate carrying a 10 kg weight 
which, together, apply a pressure of 15.2 kPa to the filter paper. After 30 s the plate 
and weight are removed, the filter papers are weighed, and their dry weight is 
subtracted to determine the rewet weight for the product.  
 
[insert Figure 5.] 
 
The final method (Fig 6) was an acquisition test formulated to represent a number of 
somewhat similar procedures that are used to measure how quickly a product 
absorbs liquid. A weighted, inverted, cylindrical cup (external and internal diameters, 
80 mm and 70 mm, respectively) is placed on the crotch region of a product laid flat 
and horizontal with its water-permeable surface facing upwards. A pump is then used 
to deliver 150 ml of normal saline into the cup at 15 ml.s-1, and the time taken for the 
liquid to be absorbed into the product is measured using a stopwatch. This time is 
designated Acquisition 1. After a delay of ten minutes, the procedure is repeated and 
the time for a second aliquot of liquid to be absorbed is measured, and designated 
Acquisition 2. The combined mass of the weight and cup is 610 g and the upper 
surface of the cup is vented with two holes to allow air to escape when liquid is 
delivered into it. The saline is stained red with fuchsin to facilitate visual inspection of 
the process through the transparent walls of the cup.  
 
[insert Figure 6.] 
  
Each laboratory ran six replicates on each of the test methods except ABL, on each 
of the product variants. Some laboratories ran more replicates with the ABL method 
(up to nine for each product variant) in order to build experience with it. Means and 
standard deviations were calculated for the results for each test method and each 
product variant for each laboratory. Finally, the Hampel estimator was used – as 
described in a German national standard [6] - to identify and remove any outliers in 
the data before calculating means and standard deviations on pooled data across all 
six laboratories for each test method, for each product variant.  
 
 
4 Results: laboratory studies 
Table 2 provides means and coefficients of variation for data for each of the five 
outcome variables (two for the acquisition method, one for each of the other three 
methods), for each of the 12 product variants, for each of the six laboratories, as well 
as coefficients of variation across means from all laboratories, for each product 
variant. It also provides means and coefficients of variation for pooled data across all 
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six laboratories for each outcome variable and each product variant, before and after 
use of the Hampel estimator (6). Data for ISO 11948-1 (Rothwell) measurements 
showed the best repeatability within laboratories (CV never exceeded 3.9% for any 
product variant in any laboratory) and between laboratories (CV for pooled data 
across all laboratories never exceeded 6.5% for any product variant, after use of the 
Hampel estimator). At the other end of the spectrum, Rewet measurements showed 
the least agreement: CV exceeded 10% for 33 of the 72 product variant / laboratory 
combinations, of which 16 were > 20%. CV for pooled data across all laboratories 
was also high: 11.2-58.7% (after use of the Hampel estimator), depending on the 
product variant. There was also evidence of systematic variation between 
laboratories: in particular, Laboratory 5 returned the lowest rewet value for each of 
the 12 product variants. The repeatability of the other three outcome variables 
(Acquisition 1, Acquisition 2 and ABL) generally fell between those for Rothwell and 
Rewet. 
 
[insert Table 2.] 
 
 
5 Methods: in use testing 
5.1 Study design 
The purpose of in-use testing was to establish the leakage performance of the 
experimental product variants as a function of urine mass for comparison with 
laboratory measurements. With Local Research Ethics Committee approval, 
residents currently using absorbent products designed to contain moderate to heavy 
urinary incontinence were recruited from five nursing homes in the London area of 
the UK. Recruits had to be at least 18 and of medium body size (defined as having a 
waist measurement of 70-110 cm) since – at the time – the ABL mannequin was only 
available in the medium size. Subjects were excluded if they were acutely ill, in the 
terminal stage of an illness, or regularly incontinent of faeces. 
 
Over 60 residents were recruited to the study, but some never started and the data 
from some others was discarded because their contribution was minimal. Testing 
was conducted during 2007 and, of the 55 participants who contributed data to the 
final analysis, there were 44 women and 11 men. Based on previous studies [7, 8] 
this was estimated to be sufficient to provide data on the 300-500 product changes 
per product variant needed to produce adequately robust estimates of leakage 
performance. The median age of subjects was 86 (range 54-101). Nine participants 
(16%) were able to consent for themselves and assent was obtained for the 
remaining 46 (84%) from their relatives or nursing home manager. 
 
During the day, 48 (87%) of the participants spent most of the time sitting (upright or 
semi-recumbent) and seven (13%) lying down. All participants spent most of the 
night lying flat or semi-recumbent in bed. Forty (73%) of the participants were unable 
to walk at all while a further 12 (22%) were able to walk with a walking aid or 
personal help. Only three (5%) were able to walk unaided. In addition, 30 (55%) of 
the participants were unable to bear weight. In summary, the test population was 
elderly and frail. 
 
Each participant used each of the 12 product variants (six for day use; six for night 
use) for two weeks, giving an overall testing period of 12 weeks. The order of testing 
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product variants was the same within each nursing home but randomised between 
nursing homes, in orders determined using Latin Squares [9]. The experimental 
products were used by the participants as a direct replacement for their usual 
products; that is, product changes were carried out in the same way as if they had 
been using their usual products. At each product change, care staff placed the used 
product in an individual labeled bag and wrote on the label the date and time of the 
product removal, the identity of the wearer, where (in bed or out of bed) and when 
(day or night) the product had mostly been worn and the extent of leakage from the 
product. As in several previous studies [3, 7, 8, 10] the extent to which the product 
(not the product wearer, note) had leaked was scored on a simple three-point scale: 
a lot of leakage (leakage beyond undergarments eg onto bedding or outer clothing); 
a little leakage (undergarments wet); or no leakage. Once every 24 hours, all the 
used products were weighed in their labeled bags and the labels completed, giving 
details of the participant and product variant code and the combined weight of bag 
and wet product. The labels were then removed from the bag and stuck into a data 
record book, and the data subsequently entered into Excel for analysis. Prior to 
analysis, a colleague who had not been involved in the data transfer checked a 
randomly selected 10% of the data, and found too few errors to justify checking the 
remaining 90%. 
 
5.2 Statistical modelling of in-use product leakage and laboratory test data 
The objective of the statistical modelling was to provide curves that estimated how 
the probability of no leakage and the probability of (no leakage or a little leakage) 
depended on the mass of the urine in a product. For convenience, rather than 
subtracting the dry mass of each individual product from its wet mass to provide urine 
mass, the mean values shown in Table 1 were used. A standard procedure for 
analysing ordinal scores with levels no leakage, a little leakage or a lot of leakage is 
to model the dependence on the factors under consideration of the odds on no 
leakage versus (a little leakage or a lot of leakage), and the odds on (no leakage or a 
little leakage) versus a lot. In each of these two cases, a commonly used model is the 














  (Equation 1) 
 
where p is the probability of no leakage and f(m) is a function of the urine mass m. 
On the left hand side of the equation, the quantity p/(1–p) is the odds on no leakage, 
and the left hand side is then the (natural) logarithm of this odds, the logit of p. Under 







    (Equation 2) 
 
For the function f(m), the data were examined to see if the simple linear function  
 
f(m) = α + βm   (Equation 3)  
was appropriate or, if it was not, whether on the right hand side m could be replaced 
by another simple function of m. Assuming that was possible, a leakage performance 
curve was then estimated by obtaining estimates of the unknown parameters  and   
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from the in-use data collected for the study. A leakage performance curve for the 
probability of no leakage or a little leakage was similarly estimated where p is now 
this probability. The above describes a model for a single product variant only but by 
introducing notation to make  and  depend on product variant number, a single 
model may be formed that includes all 12 product variants.  
 
To obtain a model for leakage performance from a particular laboratory test method, 
the product variant terms in this single model were replaced by their corresponding 
laboratory means, and the unknown parameters in this model then estimated from 
the data. 
 
After replacing the unknown parameters in the in-use model by their estimates and 
entering a urine mass of interest for m, predictions of leakage performance (eg 
estimate of probability of no leakage) for each product variant were obtained at this 
urine mass. These predictions are referred to as in-use predictions below. Similarly, 
corresponding predictions were obtained from the technical model and correlations 
between in use prediction and technical predictions calculated. 
 
 
6 Results: in use studies 
6.1 Data from weighed products 
A total of 9633 products were saved and weighed but after cleaning - and removing 
data for any subject who tested fewer than 40 individual products - this reduced to 
8877 products, relating to 55 participants. The urine mass distribution for these 8877 
saved products is shown in Fig 7 while the cumulative mass distribution for the same 
data is given in Fig 8 and various percentile urine masses used in subsequent data 
analysis, indicated. 
 
[insert Figure 7 and Figure 8.] 
 
 
6.2 Product leakage performance curves 
Fig 9 shows the leakage performance curves for all 12 product variants as a function 
of urine mass for the probability of no leakage and of (little or no leakage). It is 
apparent that nine of the 12 product variants had somewhat similar leakage 
performances while the other three (Coded 1, 2 and 3) had poorer performances.  
 
[insert Figure 9. 
 
Ten of the 12 product variants had been manufactured as five pairs, the two variants 
in each pair differing from one another in well-defined ways (eg variants with and 
without elasticated cuffs, Table 1) and the leakage performance curves for such pairs 
are given in Figs 10 to 14. Confidence intervals (95%) have been added to the 
curves for the five urine masses highlighted in Fig 8.   
 
Products 1 and 2 were inserts (Fig 1) constructed in the same way apart from having 
cuffs (Product 1) or not (Product 2). Given their common cores, their Rothwell 
absorption capacities were unsurprisingly similar (differing by ~4%), but the ABL 
value for the cuffed variant exceeded that of the uncuffed by 25%. The leakage 
                                                                 
8 
 
performance of the cuffed variant (Product 1) in in-use testing was also significantly 
better (p<0.05) than that of uncuffed Product 2 at all five urine masses and for both 
no leakage and (little or no leakage) (Fig 10). 
 
[insert Figure 10.] 
 
The impact of cuffs was less clear in the three pair-wise comparisons involving briefs 
(Fig 1). Product 6 (with cuffs) and Product 7 (without cuffs) had similar Rothwell 
absorption capacities (differing by ~3%) while the ABL value for the cuffed Product 6 
exceeded that of the uncuffed Product 7 by 13%. Differences in in-use leakage 
performance between the two variants were not significant (p>0.05) at any of the five 
urine masses for (little or no leakage), but there were some significant differences for 
no leakage: the probability of Product 7 (without cuffs) not leaking was higher than 
that for Product 6 (with cuffs) at 100 g of urine, while the reverse was true at 600 g 
(Fig 11). Products 8 (without cuffs) and 11 (with cuffs) had similar Rothwell 
absorption capacities (differing by ~1%) and the ABL value of the cuffed Product 11 
exceeded that of the uncuffed Product 8 by 6%. However, the in-use leakage 
performance of the two variants did not differ significantly (p>0.05) at any of the five 
urine masses for either no leakage or for (little or no leakage) (Fig 12). 
 
[insert Figure 11 and Figure 12.] 
 
In the third comparison of briefs with and without cuffs, Product 9 (with cuffs) and 
Products 10 (without cuffs) had similar Rothwell absorption capacities (differing by 
~1%) while the ABL value for the cuffed Product 9 exceeded that of the uncuffed 
Product 10 by 12%. Differences in in-use leakage performance between the two 
variants were not significant (p>0.05) at any of the five urine masses for no leakage, 
but there were some significant differences for (little or no leakage): the probability of 
no leakage for Product 9 (cuffed) was higher than that for Product 10 (uncuffed) at 
100g and at 200g of urine (p<0.05) (Fig 13). However, subsequent investigation 
revealed that, due to a production defect with the adhesive, the cuff system for 
Product 9 was attached in such a way that it did not lift into position readily as 
intended when put on users. This may have reduced its in-use leakage performance. 
By contrast, the technicians conducting laboratory tests would have made sure that 
the cuffs did lift into the correct position by running their fingers beneath their edge 
before testing, so separating them from the main body of the product. 
 
Finally, a useful comparison may be made between Products 4 and 5 which had 
similar insert constructions – both with cuffs – but Product 4 had a more absorbent 
core than Product 5 (Table 1). The Rothwell absorption capacity and ABL values for 
Product 4 exceeded those for Product 5 by 8% and 3%, respectively, but the modest 
improvement in in-use leakage performance in Product 4 over Product 5 did not 
reach statistical significance (p>0.05) at any of the five urine masses for either no 
leakage or for (little or no leakage) (Fig 14).  
 
[insert Figure 13 and Figure 14.] 
 
6.3 Impact on product leakage performance of participant gender, day / night 
use and use in / out of bed 
The in-use data were also examined to see if the leakage performance curves 
depended on the gender of the wearer, when the product was worn (day or night) 
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and where it was worn (in bed or out of bed). Some evidence for such a dependence 
was found in a small number of cases. For example, the results for Products 8 and 
11 for no leakage and Products 4 and 9 for (little or no leakage) suggest different 
leakage performance curves for males and females; however, these conclusions 
should be viewed with caution as there was much less data for males than females.  
A similar imbalance of data also applied for the factor when worn where the results 
for Products 0, 2, 5, 8 and 10 for no leakage and Products 5 and 8 for (little or no 
leakage) suggest different leakage performance curves for day and for night use. For 
the factor where worn the only strong evidence of a difference was for Products 2 
and 7 for (little or no leakage) where for these two variants the amount of data was 
more in balance between the two levels of the factor. 
 
However, it was finally decided not to include these three factors in constructing 
product leakage performance curves: including them would have made a significant 
difference in only a minority of cases and, also, dividing the data into an increased 
number of subcategories would have reduced the power of any analysis. 
 
 
7 Results: correlation studies 
The strength of correlations between in-use predictions and technical predictions 
(based on pooled data from all six laboratories) is summarised in Table 3 which lists 
correlation coefficients for each of the laboratory measurements. Correlations were 
generally strong, apart from those involving the probability of (little or no leakage) for 
a product containing 100 g of urine in in-use testing. This was presumably because a 
lot of leakage was a rare occurrence for such a low urine mass (Fig 9). Otherwise, 
correlation coefficients always exceeded 0.8. 
 
Correlations were quite strong for ISO 11948-1 but they were generally stronger for 
ABL, an important result given that the primary aim of the project was to compare the 
two methods. The other methods also yielded some high correlation coefficients – 
especially Acquisition 2 – but strong correlation alone is not enough to justify 
elevation to international standard status, as discussed below. 
 
[insert Table 3.] 
 
  
8 Discussion and conclusions 
The primary aim of the project was to investigate the possible adoption of the ABL 
method as a new international standard to replace or complement ISO 11948-1 and, 
in weighing the evidence, it is useful first to consider the two methods against the 
requirements for a good standard test method. Ideally, such a method would be 
simple, quick and easy to perform; involve simple and inexpensive equipment; 
produce data with good repeatability (within laboratories) and reproducibility 
(between laboratories), and show strong correlation with in-use data. Table 4 
summarises how well the ISO 11948-1 and ABL methods met these criteria. 
 
[insert Table 4.] 
 
The ISO 11948-1 method demonstrated good repeatability within - and reproducibility 
between - laboratories (Table 2) and yielded data showing reasonable correlations 
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with in-use data (Table 3). However, the results presented here support the concern 
that it may be blind to the benefits of some features of products; in particular, it did 
not detect the significant impact of leg cuffs that in-use testing revealed in comparing 
insert Products 1 and 2 (Fig 10). In view of this limitation, the method – which is the 
current international standards for estimating the leakage performance of urine 
absorbing products – should be used with caution.  
 
By comparison, the ABL method generally produced stronger correlations with in-use 
data than ISO 11948-1 (Table 3) and – unlike ISO 11948-1 – was able to detect the 
benefits of the cuffs in insert Product 2 compared with the cuff-less equivalent, 
Product 1 (Tables 1 and 2, and Fig 10). However, its repeatability and reproducibility 
were poorer (Table 2) and the equipment and procedure more complex. Indeed, the 
greater complexity probably contributed to the poorer repeatability and 
reproducibility. There is considerable potential for replicates of the equipment to differ 
from one another in unintended ways, and for different technicians to interpret 
differently the instructions for using it. For these reasons, since the completion of the 
2007 study reported here, the International Standards Organisation working group 
responsible for developing standards in this area (ISO TC173 SC3 WG2) has 
conducted several Round Robin exercises aimed at (i) identifying and describing 
precisely the critical aspects of the equipment, (ii) closely defining the test 
methodology, and (iii) capturing it in clear, unambiguous instructions. In each round, 
technicians in 6-10 laboratories in several countries have made measurements and 
pooled their data to address specific issues. The intention is that this will lead to a 
new standard which delivers the benefits described here while reducing the identified 
limitations to an acceptable level.  
 
The results for the Rewet and Acquisition methods are also interesting. Although 
some of the correlations with in-use data were impressively high (especially for 
Acquisition 2, Table 3), this is not enough to identify a test as a strong candidate as 
an international standard for measuring a particular function: correlation does not 
prove causation. The task at hand is to develop a standard that can be used to 
predict the absorption capacity of products and it is not hard to imagine a design 
which, though having low rewet and short acquisition times, also had poor absorption 
capacity. Nevertheless, it is interesting to note that – for the experimental products 
used here - this was not the case; for these products, which contained broadly similar 
materials and structures, high absorption capacity generally went hand in hand with 
low rewet and short acquisition times.    
 
Whatever it is used for, the Rewet method had poor repeatability and reproducibility, 
also showing evidence of systematic variation between laboratories (Table 3). It 
should therefore be used with caution. Acquisition 1 measurements were more 
robust: coefficients of variation for measurements within laboratories and across 
laboratory means were usually less than 5% (Table 3). Figures were a little poorer for 
Acquisition 2: coefficients of variation for measurements within laboratories were 
generally 5-10% and across laboratory means were usually 10-15% (Table 3). 
 
In conclusion this study suggests that: 
 
1. ISO 11948-1 [1] – the existing international standard for measuring the 
absorption capacity of products - should be used with caution. Although it is 
relatively simple, with good repeatability (within laboratories) and 
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reproducibility (between laboratories) and reasonable correlation with in-use 
product performance, in this study it proved blind to the benefits – apparent in 
real use - of elasticated cuffs on inserts. It is likely also to be blind to the 
impact of other features, such as the use of core structures in which the mix of 
constituent materials varies with location.   
 
2. The ABL method shows potential as a new international standard to replace or 
complement ISO 11948-1. In particular, in this study – and unlike ISO 11948-1 
- it was able to detect the in-use benefits of insert cuffs. It showed good 
correlation with in-use product performance, but it is quite complex and its 
relatively poor repeatability and reproducibility indicate that further 
development is needed to make it suitable for an international standard. This 
work has been underway since the 2007 project described here. 
 
3. The Rewet method (Spanish national standard UNE 153601-2:2008 [2]) 
showed poor repeatability and reproducibility, and it should be used with 
caution. 
 
4. The Acquisition method is supported as a robust way of measuring the speed 
with which products absorb fluid. The repeatability and reproducibility of 
measurements were good for Acquisition 1, and reasonable for Acquisition 2. 
However, although measurements generally correlated well with in-use 
leakage performance, a direct causal link is unlikely. Products with high 
absorption capacity tend also to absorb quickly.    
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0 A Insert Yes Day 2000 85.5 1.23 1.43 
1 B Insert Yes Day 1250 61.4 0.47 0.77 
2 B Insert No Day 1250 60.5 0.45 0.75 
3 C Insert Yes Day 1870 71.2 0.43 0.61 
4 D Insert Yes Night 2708 135.1 0.85 0.63 
5 D Insert Yes Night 2487 125.7 0.78 0.62 
6 E Brief Yes Day 2160 95.6 1.23 1.28 
7 E Brief No Day 2160 94.2 0.85 0.90 
8 F Brief No Night 2880 124.6 1.42 1.14 
9 E Brief Yes Night 3270 150.4 1.33 0.88 
10 E Brief No Night 3270 149.0 1.94 1.30 
11 F Brief Yes Night 2880 127.4 1.03 0.80 
 
Table 1: Principal features of the experimental product variants. Mean masses were 
for 12 pieces of each product variant. NB The design of the cuff system was not the 








Product variant 0 1 2 3 4 5 6 7 8 9 10 11
Lab 1 1886 (1.5) 1269 (2.0) 1325 (0.9) 1810 (2.0) 2863 (1.4) 2595 (0.7) 2052 (0.5) 2143 (0.6) 2761 (1.0) 3188 (1.5) 3178 (1.8) 2683 (1.6)
Lab 2 1905 (1.0) 1276 (2.1) 1320 (1.5) 1793 (2.0) 2703(2.4) 2480 (1.3) 1921 (1.8) 2117 (2.4) 2821 (2.4) 3135 (1.0) 3123 (1.6) 2728 (2.1)
Lab 3 1930 (1.3) 1383 (2.5) 1431 (0.8) 1794 (1.1) 2648 (0.8) 2619 (1.1) 2066 (1.4) 2097 (1.9) 2869 (1.8) 3324 (2.0) 3245 (2.0) 2832 (0.7)
Lab 4 1956 (1.4) 1373 (2.2) 1434 (2.1) 1899 (2.6) 2992 (0.8) 2730 (1.4) 2131 (1.4) 2192 (1.8) 2988 (1.5) 3265 (2.4) 3359 (2.7) 2892 (1.3)
Lab 5 1915 (2.8) 1315 (1.9) 1357 (1.1) 1802 (2.5) 2827 (1.3) 2548 (2.8) 2058 (1.8) 2096 (2.4) 2808 (1.1) 3256 (3.0) 3282 (2.2) 2841 (0.9)
Lab 6 1914 (1.8) 1378 (3.9) 1446 (1.9) 1935 (1.0) 2909 (1.3) 2646 (2.7) 2178 (1.4) 2161 (2.0) 2890 (0.3) 3330 (1.3) 3431 (1.0) 2951 (0.9)
CV of lab. Means (%) 1.2 3.9 4.2 3.4 4.5 3.3 4.2 1.8 2.8 2.3 3.5 3.5
All labs 1917 (2.0) 1332 (4.3) 1385 (4.1) 1839 (3.6) 2824 (4.4) 2603 (3.5) 2068 (4.1) 2134 (2.5) 2856 (2.9) 3250 (2.8) 3270 (3.7) 2821 (3.5)
All labs: after Hampel 1918 (2.2) 1332 (5.6) 1385 (4.8) 1839 (4.1) 2824 (6.5) 2603 (4.6) 2068 (5.0) 2134 (2.9) 2856 (3.5) 3250 (3.5) 3270 (4.8) 2821 (4.6)
Lab 1 503 (18.5) 413 (0.8) 309 (2.7) 419 (18.1) 759 (12.3) 760 (8.4) 564 (15.1) 515 (10.9) 792 (12.3) 802 (10.1) 712 (13.4) 849 (9.5)
Lab 2 426 (25.2) 394 (8.4) 315 (1.7) 464 (3.3) 745 (9.8) 724 (16.0) 537 (15.0) 521 (13.1) 777 (9.2) 812 (0.3) 750 (11.5) 753 (10.4)
Lab 3 517 (25.1) 434 (7.8) 413 (6.2) 534 (20.1) 769 (11.1) 716 (8.9) 775 (13.2) 579 (11.5) 832 (7.0) 793 (7.3) 771 (7.0) 891 (18.3)
Lab 4 530 (12.8) 431 (9.5) 297 (4.4) 528 (0.6) 766 (6.4) 659 (6.1) 621 (3.4) 560 (13.7) 749 (18.4) 727 (11.5) 664 (18.7) 876 (10.3)
Lab 5 664 (15.1) 465 (7.4) 403 (3.4) 526 (3.4) 721 (14.4) 737 (11.2) 647 (0.8) 613 (8.7) 776 (9.5) 859 (12.4) 649 (8.4) 817 (2.2)
Lab 6 537 (13.4) 425 (6.7) 312 (3.4) 503 (7.8) 748 (9.7) 770 (5.8) 637 (5.7) 552 (2.1) 835 (7.4) 840 (5.3) 773 (12.2) 851 (1.5)
CV of lab. Means (%) 14.6 5.5 15.2 9.2 2.3 5.4 13.2 6.6 4.3 5.6 7.5 5.9
All labs 529 (22.1) 427 (8.6) 341 (14.6) 496 (13.9) 751 (10.5) 728 (10.8) 630 (15.5) 557 (11.8) 793 (11.2) 806 (9.9) 720 (13.6) 840 (11.3)
All labs: after Hampel 526 (9.0) 427 (6.7) 328 (8.3) 496 (14.6) 739 (4.5) 737 (4.8) 614 (8.0) 557 (6.7) 800 (5.1) 814 (5.5) 720 (6.4) 840 (7.8)
Lab 1 8.8 (7.6) 17.9 (5.6) 17.2 (5.4) 16.4 (6.7) 11.8 (17.2) 15.2 (1.5) 17.2 (2.2) 16.5 (2.4) 15.1 (5.5) 10.3 (9.4) 10.2 (10.4) 15.0 (5.1)
Lab 2 6.8 (22.2) 18.1 (2.3) 17.8 (6.4) 14.7 (7.4) 9.2 (19.7) 14.1 (10.4) 18.1 (3.2) 17.3 (7.6) 14.0 (13.2) 10.6 (14.2) 9.8 (14.2) 13.5 (8.4)
Lab 3 9.5 (19.6) 20.6 (4.2) 21.3 (3.9) 16.3 (9.8) 11.2 (10.8) 14.3 (9.5) 20.0 (7.2) 19.4 (5.2) 17.4 (8.0) 8.7 (20.0) 9.5 (14.0) 17.3 (5.7)
Lab 4 5.7 (11.6) 16.8 (7.0) 16.8 (5.0) 14.4 (13.6) 7.4 (20.2) 11.9 (8.8) 16.6 (5.8) 15.4 (11.2) 11.4 (24.4) 8.3 (16.5) 8.2 (12.4) 10.9 (14.1)
Lab 5 1.3 (37.8) 11.3 (27.8) 12.7 (19.0) 11.2 (35.4) 2.2 (40.1) 3.1 (30.5) 5.2 (44.8) 12.8 (25.5) 2.6 (31.8) 1.9 (23.8) 2.5 (45.7) 3.2 (63.3)
Lab 6 10.4 (1.9) 21.0 (2.6) 18.7 (2.0) 16.1 (2.5) 11.2 (2.2) 14.0 (3.6) 18.1 (4.4) 19.2 (3.5) 18.1 (2.2) 11.0 (14.2) 10.5 (5.0) 14.7 (2.8)
CV of lab. Means (%) 46.7 19.8 16.3 13.4 41.0 37.7 33.7 14.7 43.4 40.0 35.6 40.2
All labs 7.1 (45.4) 17.6 (20.0) 17.4 (16.5) 14.8 (17.7) 8.8 (40.7) 12.1 (35.7) 15.8 (32.0) 16.8 (16.5) 13.1 (41.7) 8.5 (39.9) 8.5 (35.1) 12.4 (38.4)
All labs: after Hampel 7.1 (58.7) 17.8 (19.2) 17.4 (17.8) 15.1 (11.2) 9.2 (35.3) 13.9 (17.6) 18.0 (11.9) 16.8 (17.3) 13.7 (37.8) 8.9 (32.1) 8.95 (25.6) 12.9(34.5)
Lab 1 21.9 (2.4) 33.6 (8.5) 33.7 (4.5) 23.1 (3.9) 18.7 (6.6) 16.3 (6.9) 26.1 (4.0) 27.7 (4.1) 18.5 (2.3) 20.2 (3.7) 20.9 (3.3) 20.0 (3.0)
Lab 2 20.7 (3.4) 31.6 (5.5) 30.7 (4.5) 21.8 (4.1) 18.3 (4.8) 14.7 (4.5) 26.5 (4.2) 28.0 (6.0) 16.5 (3.2) 20.0 (2.2) 20.1 (3.8) 18.3 (4.2)
Lab 3 22.6 (4.4) 33.0 (2.1) 31.6 (6.4) 27.1 (7.9) 17.8 (13.3) 16.3 (7.9) 30.7 (7.9) 28.9 (7.2) 18.0 (5.8) 21.2 (7.0) 22.4  (2.3) 18.7 (6.6)
Lab 4 20.6 (3.1) 35.5 (5.8) 30.1 (10.0) 23.7 (8.2) 17.7 (5.8) 15.4 (5.2) 28.3 (3.3) 29.5 (1.8) 17.9 (2.1) 20.4 (3.7) 22.1 (2.4) 18.2 (3.7)
Lab 5 21.2 (4.9) 31.6 (10.5) 29.6 (6.5) 23.1 (4.0) 17.8 (6.6) 16.3 (7.0) 26.2 (4.2) 27.2 (5.0) 17.7 (4.0) 19.2 (3.7) 20.8 (1.7) 17.7 (6.0)
Lab 6 20.7 (5.0) 34.0 (4.2) 34.2 (2.2) 23.5 (7.0) 17.8 (6.6) 15.7 (3.3) 25.2 (3.9) 26.3 (5.7) 17.5 (3.1) 20.7 (5.0) 21.7 (3.8) 18.3 (5.6)
CV of lab. Means (%) 3.8 4.4 6.1 7.5 2.1 4.1 7.4 4.1 3.8 3.3 4.1 4.3
All labs 21.3 (5.1) 33.2 (7.4) 31.6 (7.9) 23.7 (9.1) 18.0 (7.2) 15.8 (6.8) 27.1 (8.3) 27.9 (6.1) 17.6 (4.9) 20.3 (5.2) 21.3 (4.7) 18.5 (6.1)
All labs: after Hampel 21.3 (5.2) 33.2 (8.4) 31.6 (9.5) 23.6 (8.3) 18.0 (5.9) 15.8 (7.4) 27.1 (7.6) 27.9 (6.7) 17.7 (5.1) 20.3 (5.8) 21.3 (5.8) 18.5 (6.9)
Lab 1 24.7 (6.0) 59.1 (8.8) 63.1 (5.2) 39.7 (7.9) 23.3 (6.8) 23.1 (7.8) 43.7 (7.4) 45.3 (6.4) 27.4 (5.7) 25.9 (7.5) 28.1 (6.8) 28.3 (6.7)
Lab 2 23.5 (6.2) 63.6 (5.7) 62.7 (2.4) 46.0 (14.9) 23.3 (13.6) 21.2 (7.0) 42.5 (7.8) 46.3 (9.7) 27.5 (3.6) 22.7 (4.8) 25.2 (5.9) 28.5 (8.8)
Lab 3 32.4 (3.7) 70.0 (3.0) 66.2 (3.7) 50.0 (6.0) 29.3 (14.3) 28.9 (9.1) 56.6 (5.3) 53.8 (3.5) 33.5 (7.2) 31.1 (6.8) 34.6 (7.9) 35.5 (5.0)
Lab 4 24.9 (5.4) 66.4 (7.2) 58.4 (4.4) 51.7 (12.8) 23.0 (7.1) 22.4 (7.4) 50.6 (8.8) 50.1 (7.4) 25.6 (3.8) 27.1 (7.3) 27.7 (7.0) 27.0 (6.1)
Lab 5 23.7 (7.4) 54.5 (9.4) 62.2 (5.1) 40.0 (10.3) 24.2 (8.2) 23.6 (8.7) 37.6 (14.2) 45.2 (8.7) 26.1 (5.5) 20.7 (5.2) 24.1 (2.8) 29.6 (6.1)
Lab 6 23.3 (3.5) 67.0 (1.3) 61.0 (2.3) 37.8 (3.9) 20.8 (3.6) 22.2 (11.9) 40.2 (2.9) 39.7 (3.4) 23.8 (3.2) 25.2 (6.8) 23.8 (6.7) 25.8 (10.2)
CV of lab. Means (%) 13.6 9.0 4.1 13.2 11.9 11.7 15.7 10.3 12.1 14.2 14.8 11.7
All labs 25.4 (13.6) 63.4 (10.2) 62.3 (5.3) 44.2 (15.6) 24.0 (14.6) 23.6 (13.6) 45.2 (16.4) 46.7 (11.5) 27.3 (12.3) 25.5 (14.5) 27.3 (15.0) 29.1 (12.7)
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Table 2: Mean (coefficient of variation) for data for each of the five outcome variables (ISO 11948-1 (Rothwell), ABL, Rewet, 
Acquisition 1, and Acquisition 2), for each of the six laboratories, for each of the 12 product variants; coefficients of variation 
across means for all laboratories; and mean (coefficient of variation) for pooled data across all six laboratories for each outcome 
variable and each product variant, before and after use of the Hampel estimator (6).


























 100   0.82 0.88 0.70 0.78 0.78 
200   0.91 0.96 0.83 0.90 0.92 
300   0.92 0.96 0.86 0.92 0.95 
450   0.93 0.95 0.87 0.94 0.96 
600   0.92 0.93 0.87 0.94 0.97 



















100   0.39 0.37 0.44 0.27 0.35 
200   0.82 0.89 0.83 0.81 0.86 
300   0.90 0.95 0.89 0.90 0.94 
450   0.93 0.95 0.90 0.94 0.97 
600   0.94 0.94 0.90 0.94 0.98 
 
 
Table 3: Correlation coefficients for in-use and technical predictions of the leakage 
performance of the product variants for each of the five test methods, having applied 
















with user data* 
Detected user benefit of 
cuffs in insert product 
variant 1 (cf variant 2)? 
ISO 11948-1 
(Rothwell) 
Yes 0.3-3.9 2.2-6.5 0.82-0.94 No 
ABL No 0.3-25.1 8.6-22.1 0.89-0.96 Yes 
 
 
Table 4: Summary of the key characteristics of the ISO 11948-1 (Rothwell) and ABL 
test methods. Range of CVs within labs = the range of the 72 coefficients of variation 
within labs (12 products x 6 labs, Table 2). Range of CVs across lab means = the 
range of the 12 coefficients of variation (1 for each product variant) across the labs 
(Table 2). * The values for correlations with user data (Table 3) exclude the result for 
(little or no leakage) at 100 g, for which neither method yielded strong correlations – 
presumably because a lot of leakage was rare at such low urine masses. 




















Fig 2: Equipment for performing ISO 11948-1: Urine absorbing aids. Part 1: Whole-


















Fig 4: The flow-rate-time profile for the 162 ml aliquots of normal saline delivered to a 
product using the ABL method. 






Fig 5: Equipment for performing the rewet test method, Spanish national standard 







Fig 6:  Equipment for performing the acquisition test method.  
 














Fig 8: Cumulative urine mass distribution in all weighed products with 25, 50, 75, 











Fig 9: Probability of no leakage (top) and little or no leakage (bottom) as a function of 








Fig 10: Comparison of in-use leakage performance curves for Product 1(Insert 
with cuff; Rothwell, 1333g; ABL, 427g) and Product 2 (Insert without cuff; 




Fig 11: Comparison of in-use leakage performance curves for Product 6 (Brief with 










Fig 12: Comparison of in-use leakage performance curves for Product 11 (Brief with 





Fig 13: Comparison of in-use leakage performance curves for Product 9 (Brief with 
cuff; Rothwell, 3250g; ABL, 806g) and Product 10 (Brief without cuff; Rothwell, 








Fig 14 Comparison of in-use leakage performance curves for Product 4 (Insert with 
cuff; Rothwell, 2824g; ABL, 751g) and Product 5 (Insert with cuff; Rothwell, 2603g; 
ABL, 728g). 
